-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Reiterates Buy on Revolution Medicines, Announces $250 Price Target

Benzinga·10/21/2026 15:12:02
TD Cowen analyst Tyler Van Buren reiterates Revolution Medicines (NASDAQ:RVMD) with a Buy and announces $250 price target.